EBNA1-specific luminescent small molecules for the imaging and inhibition of latent EBV-infected tumor cells†
Abstract
An EBNA1-specific small molecule (JLP2) has been synthesised. As a strong binder and dimerization inhibitor of EBNA1 in vitro, JLP2 may be used as a selective luminescent agent for the imaging and inhibition of latent EBV-infected cancer cells.